Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Phenylbutyrate sodium

HDAC inhibitor
BML-EI320-0001 1 g 73.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-270-303

Weak histone deacetylase (HDAC) inhibitor. Induces differentiation, growth arrest and apoptosis in a number of cell lines. Protects against cerebral ischemic injury and displays neuroprotective effect in a mouse model of Huntington’s disease. Anti-neoplastic agent and transcriptional regulator. Also acts as an inducer of tumor cytostasis and differentiation. Shows chemical chaperone activity.

Product Specification

Alternative Name:Sodium 4-phenylbutyrate, 4-Phenylbutyric acid sodium salt, SBP, 4PBA, PBNa
Formula:C10H11O2 . Na
Purity:≥98% (UHPLC)
Appearance:White to yellowish solid.
Solubility:Soluble in DMSO or water (25mg/ml).
Long Term Storage:Ambient
Use/Stability:Stable for at least 1 year after receipt when stored at +20°C. Stock solutions are stable for up to 3 months at -20°C.
Please mouse over

Product Literature References

Phenylbutyrate - a pan-HDAC inhibitor - suppresses proliferation of glioblastoma LN-229 cell line: M. Kuszaczuk, et al.; Tumour Biol. 37, 931 (2016), Application(s): Cell culture, Abstract; Full Text
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells: K. Huber, et al.; J. Biol. Chem. 286, 22211 (2011), Abstract; Full Text
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington’s disease: G. Gardian, et al.; J. Biol. Chem. 280, 556 (2005), Abstract; Full Text
Histone deacetylase inhibitor 4-phenylbutyrate suppresses GAPDH mRNA expression in glioma cells: I.B. Appelskog, et al.; Int. J. Oncol. 24, 1419 (2004), Abstract;
Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway: X. Zhang, et al.; J. Cell. Biochem. 93, 819 (2004), Abstract;
Sodium 4-phenylbutyrate protects against cerebral ischemic injury: X. Qi, et al.; Mol. Pharmacol. 66, 899 (2004), Abstract; Full Text
Butyrate as a model for "gene-regulating chemoprevention and chemotherapy.": Y. Sowa & T. Sakai; Biofactors 12, 283 (2000), Abstract;
Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors: S.D. Gore & M.A. Carducci; Expert Opin. Investig. Drugs 9, 2923 (2000), Abstract;
Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase: R.P. Warrell, et al.; J. Natl. Cancer Inst. 90, 1621 (1998), Abstract;
Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase: M.A. Lea & N. Tulsyan; Anticancer Res. 15, 879 (1995), Abstract;

Related Literature

Stem Cells
Stem Cells
Download as PDF

Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,